Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002100119-26-000117
Filing Date
2026-04-29
Accepted
2026-04-29 16:35:58
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5679
  Complete submission text file 0002100119-26-000117.txt   7526
Mailing Address 4250 CONGRESS STREET SUITE 900 CHARLOTTE NC 28209
Business Address 4250 CONGRESS STREET SUITE 900 CHARLOTTE NC 28209 980-299-5700
ALBEMARLE CORP (Subject) CIK: 0000915913 (see all company filings)

EIN.: 541692118 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-44053 | Film No.: 26916940
SIC: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD CAPITAL MANAGEMENT LLC (Filed by) CIK: 0002100119 (see all company filings)

EIN.: 392877419 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900ZEWTRLEJ6XE960
Type: SCHEDULE 13G